Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PER2 | O15055 | 8/20 | 0.40 |
| ▸ | CRY1 | Q16526 | 8/20 | 0.40 |
| ▸ | CRY2 | Q49AN0 | 8/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CD74 | P04233 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | MET | P08581 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CBX7 | O95931 | 1/20 | 0.36 |
| ▸ | CDYL2 | Q8N8U2 | 1/20 | 0.36 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.36 |
| ▸ | CDY1; CDY1B | Q9Y6F8 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3923954 | 0.89 | PER2 (0.40) | PER2CRY1CRY2ALDH1A1 | |
| SCHEMBL6735466 | 0.83 | ALDH1A1 (0.39) | ALDH1A1NPC1LMNAHPGDTSHR | |
| SCHEMBL5308775 | 0.80 | ALDH1A1 (0.55) | ALDH1A1LMNAHPGDTSHRKMT2A | |
| SCHEMBL15424910 | 0.78 | CD74 (0.39) | CD74MIFIDO1METATM | |
| SCHEMBL6236333 | 0.77 | L3MBTL1 (0.44) | ALDH1A1MIFNPC1LMNATSHR | |
| SCHEMBL9372564 | 0.76 | ATM (0.53) | ALDH1A1CD74MIFIDO1MET | |
| SCHEMBL9744272 | 0.76 | ALDH1A1 (0.43) | PER2CRY1CRY2ALDH1A1IDO1 | |
| SCHEMBL6232591 | 0.76 | NOS3 (0.41) | ALDH1A1IDO1LMNAHPGDKMT2A | |
| SCHEMBL6738246 | 0.76 | ALDH1A1 (0.40) | ALDH1A1LMNAHPGDKMT2A | |
| SCHEMBL6234062 | 0.76 | DNM1 (0.40) | ALDH1A1NPC1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040147739-A1 | Novel anti-infectives | SMITHKLINE BEECHAM CORPORATION | 2004-07-29 | — | — | US | claimed |
| US-20040147739-A1 | Novel anti-infectives | SMITHKLINE BEECHAM CORPORATION | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147739-A1 | Novel anti-infectives | RPL5, RPL7, RPL35 | PER2 3652/4885CRY1 4491/4885CRY2 3792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.